Practitioners are required to comply with the following minimum
health standards:
A. A practitioner shall perform all body art procedures in accordance
with universal precautions set forth by the U.S. Centers for Disease
Control and Prevention.
B. A practitioner shall refuse service to any person who may be under
the influence of alcohol or drugs.
C. Practitioners who use ear-piercing systems must conform to the manufacturer's
directions for use, and to applicable U.S. Food and Drug Administration
requirements. No practitioner shall use an ear-piercing system on
any part of the client's body other than the lobe of the ear.
Prior to performing a body art procedure on a client, the practitioner
shall:
A. Inform the client, verbally and in writing, that the following health
conditions may increase health risks associated with receiving a body
art procedure:
(2) History of hemophilia (bleeding);
(3) History of skin diseases, skin lesions, or skin sensitivities to
soaps, disinfectants etc.;
(4) History of allergies or adverse reactions to pigments, dyes, or other
sensitivities;
(5) History of epilepsy, seizures, fainting, or narcolepsy;
(6) Use of medications such as anticoagulants, which thin the blood and/or
interfere with blood clotting; and
(7) Any other conditions such as hepatitis or HIV.
B. Require that the client sign a form confirming that the above information was provided, that the client does not have a condition that prevents them from receiving body art, that the client consents to the performance of the body art procedure and that the client has been given the aftercare instructions as required by §
405-18.
Any item or instrument used for body art that is contaminated
during the procedure shall be discarded and replaced immediately with
a new disposable item or a new sterilized instrument or item before
the procedure resumes.
Preparation and care of a client's skin area must comply
with the following:
A. Any skin or mucosa surface to receive a body art procedure shall
be free of rash or any visible infection.
B. Before a body art procedure is performed, the immediate skin area
and the areas of skin surrounding where the body art procedure is
to be placed shall be washed with soap and water or an approved surgical
skin preparation. If shaving is necessary, single-use disposable razors
or safety razors with single-service blades shall be used. Blades
shall be discarded after each use, and reusable holders shall be cleaned
and autoclaved after use. Following shaving, the skin and surrounding
area shall be washed with soap and water. The washing pad shall be
discarded after a single use.
C. In the event of bleeding, all products used to stop the bleeding
or to absorb blood shall be single use, and discarded immediately
after use in appropriate covered containers, and disposed of in accordance
with 105 CMR 480.000.
Petroleum jellies, soaps, and other products used in the application
of stencils shall be dispensed and applied on the area to receive
a body art procedure with sterile gauze or other sterile applicator
to prevent contamination of the original container and its contents.
The applicator or gauze shall be used once and then discarded.
The practitioner shall provide each client with verbal and written
instructions on the aftercare of the body art site.
A. The written aftercare instructions shall advise the client:
(1) On the proper cleansing of the area which received the body art;
(2) To consult a health care provider for:
(a)
Unexpected redness, tenderness or swelling at the site of the
body art procedure;
(c)
Unexpected drainage at or from the site of the body art procedure;
or
(d)
A fever within 24 hours of the body art procedure; and
(3) Of the address and phone number of the establishment.
B. A copy shall be provided to the client.
C. A model set of aftercare instructions shall be made available by
the Board.
Contaminated waste shall be stored, treated and disposed in
accordance with 105 CMR 480.000: Storage and Disposal of Infectious
or Physically Dangerous Medical or Biological Waste, State Sanitary
Code, Chapter VIII.